The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
Level | Code | Title | |
---|---|---|---|
1 | D | Dermatologicals | |
2 | D07 | Corticosteroids, dermatological preparations | |
3 | D07X | Corticosteroids, other combinations | |
4 | D07XC | Corticosteroids, potent, other combinations |
Code | Title | |
---|---|---|
D07XC01 | Betamethasone | |
D07XC02 | Desoximetasone | |
D07XC03 | Mometasone | |
D07XC04 | Diflucortolone | |
D07XC05 |
Active Ingredient | Description | |
---|---|---|
Betamethasone |
Betamethasone is a glucocorticoid which is about eight to ten times as active as prednisolone on a weight-for-weight basis. Betamethasone has anti-inflammatory, antipruritic, and vasoconstrictive properties. |
|
Desoximetasone |
Desoximetasone is a synthetic corticosteroid. Topical corticosteroids share anti-inflammatory, antipruritic and vasoconstrictive actions. Desoximetasone is used for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. |
|
Diflucortolone |
Diflucortolone is a topically acting fluoridated corticosteroid which suppresses inflammation in inflammatory and allergic skin conditions and alleviates the subjective complaints such as itching, burning and pain. |
|
Fluocortolone |
Fluocortolone pivalate inhibits inflammatory and allergic skin reactions, and alleviates subjective complaints such as pruritus, smarting, and pain. The substance reduces dilatation of the capillaries, oedema of the interstitial cells and infiltration of the tissues. Capillary multiplication is inhibited. |
|
Mometasone |
Mometasone is a topical glucocorticoid with local anti-inflammatory properties. It is likely that much of the mechanism for the effects of mometasone lies in its ability to inhibit the release of mediators of the inflammatory cascade. |
Title | Information Source | Document Type | |
---|---|---|---|
DIPROSALIC Ointment | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC |